Eitan Group, a global leader in advanced infusion therapy solutions across the care continuum, today announced a distribution agreement with Canadian Hospital Specialties Ltd. (CHS), a national specialty distributor and manufacturer of medical and surgical products, to supply and support Eitan Group’s Sapphire infusion system hospital and alternate site customers across Canada.

“CHS works to introduce the most advanced medical technology to the Canadian market in our mission to improve patient care and outcomes,” said Mike Canzoneri, CEO of CHS. “We are aligned with Eitan Group in our innovation focus; we believe our customers will immediately see the benefits of implementing Eitan Group’s future-ready, intuitive Sapphire platform.”

Sapphire customers will receive immediate attention and support across Canada with CHS’s large, capable sales organization.  

“CHS has significant experience in hospital-based and alternate site infusion and has a reputation for providing high quality products with excellent customer service. CHS is an ideal partner to bring Sapphire to the Canadian market,” said Roger Massengale, CEO of Eitan Group North America.

Eitan Group’s flagship Sapphire infusion systems are installed worldwide, with more than 100,000 devices in the market. The robust infusion platform is lightweight with a small footprint, features an intuitive touch screen and is designed for ease-of-use, requiring minimal training for medical professionals.